Several law firms issue notices to investors regarding a securities fraud class action involving GeneDx Holdings Corp. (NASDAQ: WGS). The lawsuits target the company over alleged securities law violations tied to the company’s common stock purchases during a defined class period from April 16, 2025 through May 4, 2026. Multiple notices describe the filing as a class action and invite investors who bought shares within that period to consider applying to serve as lead plaintiff. Deadlines highlighted across the notices include an August 3, 2026 cutoff for submitting lead plaintiff applications. One notice states that investors with losses may contact specific representatives at the firms issuing the alerts, including Rosen Law Firm, Pomerantz LLP, and ClaimsFiler, which characterizes itself as a shareholder information service. Another notice emphasizes the opportunity for affected investors to take part in the process of selecting lead plaintiffs. The communications do not indicate the outcome of the case and present the information as steps for investor participation and upcoming procedural deadlines.